Manchin, Capito Announce More Than $500,000 for Alzheimer’s Research at WVU

Charleston, WV – U.S. Senators Joe Manchin (D-WV) and Shelley Moore Capito (R-WV), members of the Senate Appropriations Committee, today announced $507,613 in funding from the U.S. Department of Health and Human Services (HHS) for clinical research related to neurological disorders at West Virginia University (WVU). Specifically, this funding will examine psychosocial stress-induced vascular contributions to cognitive impairment and Alzheimer's disease.

 

“Alzheimer’s is a heartbreaking disease that affects more than 39,000 West Virginians. It is incredibly important to invest in research to help us learn more about the causes of Alzheimer’s and to find a cure for this horrible disease. That is why I’m pleased HHS is investing in Alzheimer’s research at West Virginia University, and I look forward to seeing the impacts for West Virginians who live with Alzheimer’s and their families, friends and loved ones. We must continue to work together to find a cure, and I am committed to these efforts,” Senator Manchin said.

“Alzheimer’s disease is a deeply personal issue to me, and I know firsthand the strain it has on individuals and their loved ones. That’s why I have worked to robustly fund research into Alzheimer’s disease and Dementia and worked hard to advocate for the resources our medical institutions need to pursue a cure. I’m encouraged by this project announcement today, which will support research efforts at WVU,” Senator Capito said.